A detailed history of Simplex Trading, LLC transactions in Protara Therapeutics, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 373 shares of TARA stock, worth $2,167. This represents 0.0% of its overall portfolio holdings.

Number of Shares
373
Holding current value
$2,167
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$1.7 - $2.4 $634 - $895
373 New
373 $0
Q1 2024

Apr 25, 2024

BUY
$1.86 - $4.83 $33,201 - $86,215
17,850 New
17,850 $71,000
Q2 2023

Aug 04, 2023

BUY
$2.27 - $3.59 $442 - $700
195 New
195 $0
Q1 2022

May 02, 2022

SELL
$4.19 - $6.9 $2,409 - $3,967
-575 Closed
0 $0
Q4 2021

Feb 23, 2022

SELL
$6.15 - $7.76 $36 - $46
-6 Reduced 1.03%
575 $3,000
Q2 2021

Aug 12, 2021

BUY
$8.68 - $16.99 $5,043 - $9,871
581 New
581 $5,000

Others Institutions Holding TARA

About Protara Therapeutics, Inc.


  • Ticker TARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,267,400
  • Market Cap $65.5M
  • Description
  • Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...
More about TARA
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.